Effects of Pravastatin on the Expression of ATP-Binding Cassette Transporter A1

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2004-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/JPET.104.068213PMID 15210833
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced Connexin43 Expression Inhibits Atherosclerotic Lesion Formation in Low-Density Lipoprotein Receptor–Deficient Mice

  2003cited by this paper
• Efflux and Atherosclerosis The Clinical and Biochemical Impact of Variations in the ABCA1 Gene

  2003cited by this paper
• Does pravastatin affect circulating levels of soluble TNF receptor 2 in hypercholesterolemic patients?

  2003cited by this paper
• Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model

  2003cited by this paper
• Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations Published, JLR Papers in Press, November 4, 2002. DOI 10.1194/jlr.M200414-JLR200

  2003cited by this paper
• Expression, regulation, and activity of ABCA1 in human cell lines.

  2003cited by this paper
• The 3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitor Pravastatin Reduces Disease Activity and Inflammation in Dextran-Sulfate Induced Colitis

  2003cited by this paper
• Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis.

  2003influential reference
• Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages

  2002influential reference
• Identification of macrophage liver X receptors as inhibitors of atherosclerosis

  2002influential reference
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Rapid quantification of murine ABC mRNAs by real time reverse transcriptase-polymerase chain reaction Published, JLR Papers in Press, September 1, 2002. DOI 10.1194/jlr.D200020-JLR200

  2002cited by this paper
• Accumulation of Foam Cells in Liver X Receptor-Deficient Mice

  2002influential reference
• Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues

  2002cited by this paper
• Stimulation of Lipogenesis by Pharmacological Activation of the Liver X Receptor Leads to Production of Large, Triglyceride-rich Very Low Density Lipoprotein Particles*

  2002cited by this paper
• Synthetic LXR ligand inhibits the development of atherosclerosis in mice

  2002cited by this paper
• Phospholipid Transfer Protein Is Regulated by Liver X Receptors in Vivo *

  2002cited by this paper
• A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis.

  2001cited by this paper
• Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.

  2001cited by this paper
• Dual Mechanisms of ABCA1 Regulation by Geranylgeranyl Pyrophosphate*

  2001cited by this paper
• A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis

  2001cited by this paper
• Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels.

  2001cited by this paper
• Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency.

  2000cited by this paper
• Role of LXRs in control of lipogenesis.

  2000cited by this paper
• Human White/Murine ABC8 mRNA Levels Are Highly Induced in Lipid-loaded Macrophages

  2000cited by this paper
• Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor.

  2000cited by this paper
• Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha.

  2000cited by this paper
• PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.

  2000cited by this paper
• Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

  2000cited by this paper
• Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis.

  2000cited by this paper
• High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1.

  2000influential reference
• Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease.

  1999cited by this paper
• Regulation of Peroxisome Proliferator-Activated Receptor γ Expression by Adipocyte Differentiation and Determination Factor 1/Sterol Regulatory Element Binding Protein 1: Implications for Adipocyte Differentiation and Metabolism

  1999cited by this paper
• Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux.

  1997cited by this paper
• The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism.

  1997influential reference
• HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients.

  1995cited by this paper
• Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.

  1995cited by this paper
• Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice.

  1994cited by this paper
• The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects.

  1994cited by this paper
• Regulation of the mevalonate pathway

  1990cited by this paper
• The National Cholesterol Education Program.

  1989cited by this paper
• The plasma lecithins:cholesterol acyltransferase reaction.

  1968cited by this paper

• Statins to Prevent Pacing-Induced Cardiomyopathy: Evidence from the Bench applied to Clinical Studies.

  2022cites this paper
• Potential Therapeutic Agents That Target ATP Binding Cassette A1 (ABCA1) Gene Expression

  2022cites this paper
• Molecular-level changes induced by hydroxycinnamic acid derivatives in HepG2 cell lines: Comparison with pravastatin.

  2021cites this paper
• Cholesterol transporter proteins in HepG2 cells can be modulated by phenolic compounds present in Opuntia ficus-indica aqueous solutions

  2020cites this paper
• Lipid lowering therapy in cardiovascular disease: From myth to molecular reality.

  2020cites this paper
• Effect of Fermented Pentaclethra Macrophylla Benth (African Oil Bean) Seed Extract on Plasma Lipid Profile in Healthy Rat Model-A Preliminary Study

  2019cites this paper
• Downregulation of ABCA1 and ABCG1 transporters by simvastatin in cholangiocarcinoma cells

  2019cites this paper
• Repurposing of statins via inhalation to treat lung inflammatory conditions

  2018cites this paper
• Title Profile of rhythmic gene expression in the livers of obese diabetic

  2017cites this paper
• Pravastatin activates the expression of farnesoid X receptor and liver X receptor alpha in Hep3B cells.

  2014cites this paper
• Comparative effects of statins on murine cardiac gene expression profiles in normal mice.

  2013cites this paper
• Effects of pitavastatin on HDL metabolism

  2013cites this paper
• Pleiotropic Effects of HMG-CoA Reductase Inhibitors - studies in vitro and in vivo

  2012cites this paper
• HNF4&agr; Increases Liver-Specific Human ATP-Binding Cassette Transporter A1 Expression and Cholesterol Efflux to Apolipoprotein A-I in Response to Cholesterol Depletion

  2012cites this paper
• Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport

  2012cites this paper
• Effect of 6-O-α-maltosyl-β cyclodextrin and its cholesterol inclusion complex on cellular cholesterol levels and ABCA1 and ABCG1 expression in mouse mastocytoma P-815 cells.

  2012cites this paper
• Coronary Heart Disease in Familial Hypercholesterolemia

  2012cites this paper
• Influence of Dosing Time on the Efficacy and Safety of Finasteride in Rats

  2011cites this paper
• Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells.

  2010cites this paper
• HMG-CoA Reductase Inhibitors (Statins) Activate Expression of PPARα/PPARγ and ABCA1 in Cultured Gallbladder Epithelial Cells

  2010cites this paper
• Statins and ALS: the possible role of impaired LXR signaling.

  2010cites this paper
• Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions.

  2010cites this paper
• ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells.

  2009cites this paper
• Cytochrome P450 et activation génétique — de la pharmacologie à l’élimination du cholestérol et à la régression de l’athérosclérose

  2009cites this paper
• Adverse effects of statins - mechanisms and consequences.

  2009cites this paper
• Liver X receptors (LXR) as therapeutic targets in dyslipidemia.

  2008cites this paper
• The effect of statins on ABCA1 and ABCG1 expression in human macrophages is influenced by cellular cholesterol levels and extent of differentiation.

  2008cites this paper
• Cytochrome P450 and gene activation—from pharmacology to cholesterol elimination and regression of atherosclerosis

  2008cites this paper
• Liver X receptors (LXRs). Part II: non-lipid effects, role in pathology, and therapeutic implications.

  2007cites this paper
• Study of ATP-binding Cassette Transporter A1 (ABCA1)-mediated Cellular Cholesterol Efflux in Diabetic Golden Hamsters

  2007cites this paper
• FACULDADE DE CIÊNCIAS FARMACÊUTICAS Programa de Pós-Graduação em Farmácia Área de Análises Clínicas Estudo da expressão gênica e de polimorfismos do gene ABCA1 em indivíduos sob terapia hipolipemiante

  2007cites this paper
• El monocito/macrófago como diana terapéutica en la aterosclerosis

  2007cites this paper
• Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells.

  2006cites this paper
• Pitavastatin Effect on ATP Binding Cassette A1-Mediated Lipid Efflux from Macrophages: Evidence for Liver X Receptor (LXR)-Dependent and LXR-Independent Mechanisms of Activation by cAMP

  2006cites this paper
• Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes.

  2006cites this paper
• Profile of rhythmic gene expression in the livers of obese diabetic KK-A(y) mice.

  2006cites this paper
• Rhythmic messenger ribonucleic acid expression of clock genes and adipocytokines in mouse visceral adipose tissue.

  2005cites this paper
• Transcriptional regulatory networks in lipid metabolism control ABCA1 expression.

  2005cites this paper
• ABCA1 and atherosclerosis

  2005cites this paper
• Daily Rhythms of P‐glycoprotein Expression in Mice

  2005cites this paper
• Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.

  2005cites this paper
• Regulation of cholesterol 7alpha-hydroxylase mRNA expression in C57BL/6 mice fed an atherogenic diet.

  2005cites this paper
• Regulation of cholesterol 7α-hydroxylase mRNA expression in C57BL/6 mice fed an atherogenic diet

  2005cites this paper
• Acute digoxin loading reduces ABCA8A mRNA expression in the mouse liver

  2005cites this paper